Prot# 09-266-B//NU UC10N01: Randomized Phase II Trial of Everolimus Versus Placebo as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) (CRAD001CUS129T)

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date3/1/1012/1/15

Funding

  • University of Chicago (09-266-B//NU UC10N01)
  • Novartis Pharmaceuticals Corporation (09-266-B//NU UC10N01)